Five states failed the first-ever prostate cancer state-by-statereport card issued by the National Prostate Cancer Coalition.Alabama, Arkansas, Idaho, Mississippi, and Wisconsin did not makethe grade while California, Connecticut, Kansas, and New York allearned As.
Five states failed the first-ever prostate cancer state-by-state report card issued by the National Prostate Cancer Coalition. Alabama, Arkansas, Idaho, Mississippi, and Wisconsin did not make the grade while California, Connecticut, Kansas, and New York all earned As.
“Many states are not doing even the simplest things when it comes to fighting prostate cancer,” said Richard Atkins, MD, of the National Prostate Cancer Coalition. “Early detection saves lives, and far too many states don’t encourage men to know the risks and to get tested.”
The report cards are a result of a study in which each state is graded based on current prostate cancer screening rates, mortality rates, and if each state currently has laws in place guaranteeing insurance coverage for testing.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.